Navigation Links
How the demons of dementia possess and damage brain cells
Date:3/3/2010

A study from EPFL's (Ecole Polytechnique Fdrale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's patients, may lead to neurodegeneration. Researchers in Lausanne have studied how the functions of certain cells called astrocyteswhich normally protect, repair, and transfer energy to neuronsare impaired when "possessed" by aggregated Amyloid-Beta.

Alzheimer's disease currently affects more than 26 million people worldwide and estimates of up to four times as many sufferers by 2050 has made studying its causes a top priority for neuroscientists.

While the exact mechanisms by which the formation of plaques occurs and how they cause neurodegeneration and dementia is still a matter of debate in the scientific world, this study sheds a new light on how astrocytes may participate in the development of Alzheimer's disease. This new understanding of the interaction between Amyloid-Beta and astrocytes could lead to more effective therapies for Alzheimer's disease by trying to rescue astrocytic functions by deactivating the scavenger receptors.

The current study explores the causal relationship between the build-up of the Amyloid-Beta protein, associated with the formation of plaques, and the impairment of astrocyte's functions. Pierre Magistretti, director of the Brain Mind Institute and the Center for Psychiatric Neurosciences at CHUV/UNIL, and Igor Allaman, post doctoral fellow in Magistretti's lab, have succeeded in determining how built-up Amyloid-Beta infiltrates the astrocyte cells and alters their proper functioning, thus leading to the death of surrounding neurons. "To penetrate the astrocyte, the pathological protein goes through a 'scavenger' receptor." explains Igor Allaman. "Our study has shown that if we impair Amyloid-Beta build-up, or activation of this receptor, astrocytes continue to fulfill their normal neuroprotective functions even in the presence of the Amyloid-Beta."


'/>"/>

Contact: Michael Mitchell
michael.mitchell@epfl.ch
41-798-103-107
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert  

Related biology news :

1. Aware, Inc. Joins HIMSS10 Interoperability Showcase to Demonstrate Standards-Based Medical Image Sharing
2. Researchers demonstrate nanoscale X-ray imaging of bacterial cells
3. Munich lab demonstrates diesel truck engine with barely measurable emissions
4. Scientists demonstrate link between genetic defect and brain changes in schizophrenia
5. Ben-Gurion University Alzheimers researcher demonstrates specific immune response to vaccine
6. Case Western Reserve University researcher demonstrates that messenger RNA are lost in translation
7. Scientists demonstrate importance of niche differences in biodiversity
8. University of Leicester geologists demonstrate extent of ancient ice age
9. Demonstration Features Commercial Technology for Combating Terrorism
10. Demonstration Features Commercial Technology for Combating Terrorism
11. Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How the demons of dementia possess and damage brain cells
(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
(Date:12/20/2016)... , Dec. 20, 2016 The rising ... rental and leasing is stoking significant interest in ... frequency technology, Bluetooth low energy (BLE), biometrics and ... the next wave of wireless technologies in the ... system to advanced access systems opens the market ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... LANSING, Mich. , Jan. 24, 2017  Neogen ... it had terminated its agreement with SenesTech Incorporated (NASDAQ: ... marketing of a rodenticide being developed by SenesTech. The ... to the time when the SenesTech product was approved ... final EPA approval provided that the product could only ...
(Date:1/24/2017)... Jan. 24, 2017   Bracket , a leading ... the addition of Jennifer Peters to its ... and General Manager for the Scientific Services division. In ... work in Rater Training, Quality Assurance, and Electronic Clinical ... strong skillset and demonstrated record building technology-based businesses in ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... solutions, announces the appointment of Steven F. McAllister as Executive Vice President and ... in both the U.S. and international markets. Beginning his career at Howmedica, Inc., ...
(Date:1/24/2017)... ... January 24, 2017 , ... Nor-Tech’s leading-edge demo ... with user-friendly bootable Intel KNL. , Currently Cal Tech researchers are testing ... cluster. The demo cluster is a no-cost, no-strings opportunity for current and prospective ...
Breaking Biology Technology: